CJC-1295 WITH DAC 2MG

CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that increases plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). DAC is an additive moiety that prolongs the plasma half-life of CJC-1295.

CJC-1295, also known as DAC:GRF (short for drug affinity complex:growth hormone-releasing factor), is a synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies. It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life.

CJC-1295 markedly increases plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels in both animals and humans. With a single injection, in human subjects, CJC-1295 increases plasma GH levels by 2- to 10-fold for 6 days or longer and plasma IGF-1 levels by 0.5- to 3-fold for 9 to 11 days. The drug has an estimated half-life of about 6 to 8 days in humans. With multiple doses of CJC-1295, IGF-1 levels were found to remain elevated in humans for up to 28 days.

CJC-1295 has been shown to extend the half-life and bioavailability of growth-hormone-releasing hormone 1-29 and stimulate insulin-like growth factor 1 secretion. It increases the half-life of acting agents by bioconjugation.

CJC-1295 was under investigation for the treatment of lipodystrophy and growth hormone deficiency and reached phase II clinical trials but was discontinued upon the death of one of the trial subjects.The attending physician of the trial believed that the most likely explanation for the incident was that the patient had asymptomatic coronary artery disease with plaque rupture and occlusion, and that the occurrence was unrelated to treatment with CJC-1295. Research was terminated nonetheless as a precaution. CJC-1295 has found grey market use for bodybuilding purposes, with this, in some countries such as the Netherlands, being an illicit use.

Benefits of CJC-1295 

CJC-1295 is associated with a wide array of benefits. Since the peptide works via the release of Growth Hormone and IGF-1, you can already expect a long list of effects! 

Increase in Lean Muscle Mass

One of the BIGGEST advantages you can gain through CJC-1295 is an increase in lean muscle mass (4). The peptide does this via an increase in muscle protein synthesis and mass growth.

The CJC-1295 and Ipamorelin stack offers a more significant increase in muscle growth and strength.

Triggers Fat Loss

Other than that, CJC-1295 is widely known for its fat-loss attributes (5). Prolactin, another hormone secreted by the anterior pituitary, is associated with slowing the body’s metabolism.

This is soon followed by a more significant visceral fat accumulation, one of the major risk factors for cardiovascular diseases.

However, with CJC-1295, you’re in safe hands! The peptide slows the release of prolactin and contributes to the rapid loss of unwanted fat. 

May Improve Sleep Cycle

Although limited studies are available, some scientists do claim CJC-1295 is involved in sleep improvement. Since GHRH is seen to promote deep and quality sleep, it makes sense that, being a GHRH analog, CJC-1295 does the same.

With better sleep, your body gets a chance to repair tissue, make more neural connections, and cause an increase in muscle and bone density.